Biohaven

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Biohaven 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BHVN

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT. 

CEO
Vladimir Coric
CEOVladimir Coric
Employees
256
Employees256
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2022
Founded2022
Employees
256
Employees256

BHVN Key Statistics

Market cap
1.63B
Market cap1.63B
Price-Earnings ratio
-1.71
Price-Earnings ratio-1.71
Dividend yield
Dividend yield
Average volume
2.58M
Average volume2.58M
High today
$16.27
High today$16.27
Low today
$15.56
Low today$15.56
Open price
$15.82
Open price$15.82
Volume
3.84M
Volume3.84M
52 Week high
$55.70
52 Week high$55.70
52 Week low
$14.69
52 Week low$14.69

Analyst ratings

100%

of 16 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own BHVN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.